Even in patients with HCC, MTA1 expression was higher compared to tumor-adjacent normal tissue, and the high expression of MTA1 was correlated with low DNA-PK and phosphorylated H1.2. This evidence concerns the gene PRKDC and hepatocellular carcinoma.